Research and Markets: Routine and Special Coagulation Tests: Review of Emerging Assays and Suppliers Developing New Coagulation Technologies and Products
* Reuters is not responsible for the content in this press release.
DUBLIN--(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/75c423/routine_and_specia) has announced the addition of the "Routine and Special Coagulation Tests: Review of Emerging Assays and Suppliers Developing New Coagulation Technologies and Products" report to their offering. The report presents an overview of the clinical significance and market needs for major coagulation laboratory tests, as well as extensive listings of companies developing or marketing new coagulation technologies and products. Key Topics Covered: 1. Introduction 2. Activated Clotting Time (ACT) 3. Activated Protein C Resistance 4. Activated PTT (APTT) 5. Alpha-2 Antiplasmin 6. Antithrombin III 7. Bleeding Time 8. D-Dimer 9. Factor Assays * Introduction * Factor II * Factor V * Factor V Leiden * Factor VII * Factor VIII * Factor IX * Factor IXa * Factor X (Stuart Factor) * Factor Xa * Factor XI * Factor XII * Factor XIII 10. Fibrin Degradation Products 11. Fibrinogen 12. Fletcher Factor/Pre-Kallikrein Factor Activation 13. Heparin/Anti-Factor Xa 14. Heparin-Induced Thrombocytopenia 15. Plasmin 16. Plasminogen 17. Plasminogen Activator Inhibitor 18. Platelet Function/Aggregation 19. Protein C 20. Proteins S 21. Prothrombin Mutation 22. Prothrombin Time (PT) 23. Reptilase Time 24. Thrombin Time 25. Von Willebrand's Factor Fav/Ag For more information visit http://www.researchandmarkets.com/research/75c423/routine_and_specia Research and Markets Laura Wood, Senior Manager, press@researchandmarkets.com U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters